2013
DOI: 10.1016/j.ejmech.2012.12.011
|View full text |Cite
|
Sign up to set email alerts
|

Predictive modeling of insulin release profile from cross-linked chitosan microspheres

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
48
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 88 publications
(52 citation statements)
references
References 24 publications
2
48
0
Order By: Relevance
“…Specifically, insulin-loaded L/C NPs could be obtained without the use of cross-linking agents such as tripolyphosphate 29 or glutaraldehyde 26 through a simpler preparation procedure, which did not require homogenization or repeated washing and precipitation as done in previous studies. 30,27 Furthermore, the EE of self-assembled insulinloaded L/C NPs was much higher than that of other delivery systems.…”
Section: Discussionmentioning
confidence: 99%
“…Specifically, insulin-loaded L/C NPs could be obtained without the use of cross-linking agents such as tripolyphosphate 29 or glutaraldehyde 26 through a simpler preparation procedure, which did not require homogenization or repeated washing and precipitation as done in previous studies. 30,27 Furthermore, the EE of self-assembled insulinloaded L/C NPs was much higher than that of other delivery systems.…”
Section: Discussionmentioning
confidence: 99%
“…The CSN were prepared using an emulsion crosslinking method [24][25][26][27]. A stock solution of 2% (v/v) glutaraldehyde was prepared by dissolving 4.0 mL of glutaraldehyde in 46 mL of 1,4-dioxane.…”
Section: Preparation Of Csn Using An Emulsion Crosslinking Methodsmentioning
confidence: 99%
“…ACCEPTED MANUSCRIPT 21 In addition to thermal stress [59], proteins are prone to denaturation and aggregation by various factors in processes like the solvent evaporation/extraction methods described above, including exposure to high shear forces during processing (particularly emulsification), exposure to the large interfacial area between the emulsified oil and aqueous phases or at the air-water interface of small droplets, as well as interaction with an encapsulating polymer or organic solvent. The loss of protein activity by denaturation/aggregation can be minimized by using a number of stabilizers such as polyols, albumins and other proteins, surfactants, poloxamers, cyclodextrins, etc, depending on the stresses involved in the manufacturing processes for various oral drug delivery systems, which are further highlighted below.…”
Section: Accepted Manuscriptmentioning
confidence: 99%